![Inès Holzbaur](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Inès Holzbaur
Founder at AmorChem Financial, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Louis P. Lacasse | M | 67 |
AgeChem Financial, Inc.
![]() AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada.
GeneChem Management, Inc.
![]() GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal.
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 27 years |
Elizabeth Douville | M | - |
GeneChem Management, Inc.
![]() GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal.
AgeChem Financial, Inc.
![]() AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada.
AmorChem Financial, Inc.
![]() AmorChem Financial, Inc. Financial ConglomeratesFinance AmorChem Financial, Inc. provides financial investment services. The company is headquartered in Westmount, Canada. | 27 years |
Perry B. Molinoff | M | 84 |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | - |
Martial Lacroix | M | - |
AgeChem Financial, Inc.
![]() AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada.
GeneChem Management, Inc.
![]() GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | 27 years |
Freda Miller | M | - |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 24 years |
Alex MacKenzie | M | - |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 24 years |
Robert Korneluk | M | - |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 24 years |
Pierre Thibault | M | - |
SpecificiT Pharma, Inc.
![]() SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada. | - |
Serge Langford | M | - |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | - |
John W. Gillard | M | - |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | - |
Joe Regan | M | 56 |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | - |
Trudie Resch | F | - |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | 17 years |
Lennie Ryer | M | 64 |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | - |
Michael B. Cross | M | 59 |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | - |
Claude Perreault | M | - |
SpecificiT Pharma, Inc.
![]() SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada. | - |
Denis Roy | M | - |
SpecificiT Pharma, Inc.
![]() SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada. | - |
Jean Delisle | M | - |
SpecificiT Pharma, Inc.
![]() SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Giovanni A. Ferrara | M | 55 |
GeneChem Management, Inc.
![]() GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | 4 years |
Nicola Urbani | M | - |
GeneChem Management, Inc.
![]() GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | - |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 19 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Inès Holzbaur
- Personal Network